Brainsway (BRSYF) Change in Receivables (2025 - 2026)

Brainsway posted quarterly Change in Receivables of -$3.5 million for Q1 2026, down 47.08% year-on-year from -$6.5 million in Q1 2025, and down 47.08% on a QoQ basis from -$2.3 million in Q1 2025.

Brainsway (BRSYF) has 2 years of Change in Receivables data on file, last reported at -$3.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 42.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -444.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -13.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 117.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 117.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -124.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -141.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 123.50 Mn
10 Brainsway - - 11.68 Mn -3.46 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.46 Mn
Mar 31, 2026 -3.46 Mn
Mar 31, 2025 -2.35 Mn
Mar 31, 2025 -2.35 Mn